Helicobacter pylori infection combined with DENA revealed altered expression of p53 and 14-3-3 isoforms in Gulo−/− mice  by Nagappan, Arulkumar et al.
Chemico-Biological Interactions 206 (2013) 143–152Contents lists available at ScienceDirect
Chemico-Biological Interactions
journal homepage: www.elsevier .com/locate /chembiointHelicobacter pylori infection combined with DENA revealed altered
expression of p53 and 14-3-3 isoforms in Gulo/ mice0009-2797 2013 The Authors. Published by Elsevier Ireland Ltd.
http://dx.doi.org/10.1016/j.cbi.2013.09.002
⇑ Corresponding author. Tel.: +82 55 772 2346; fax: +82 55 772 2349.
E-mail address: gonskim@gnu.ac.kr (G.S. Kim).
1 These two authors contributed equally to this study.
Open access under CC BY-NC-ND license. Arulkumar Nagappan a,1, Hyeon Soo Park a,1, Kwang Il Park b, Gyeong Eun Hong a, Silvia Yumnama,
Ho Jeong Lee a, Mun Ki Kim a, Eun Hee Kim c, Won Sup Lee d, Wang Jae Lee e, Myung Je Cho f,
Woo Kon Lee f, Chung Kil Won a, Jae Hyeon Cho a, Gon Sup Kim a,⇑
aResearch Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, 900 Gajwadong, Jinju, Gyeongnam 660-701, Republic of Korea
bDepartment of Biological Science, Center for Colon Cancer Research, University of South Carolina, Columbia, SC 29208, USA
cDepartment of Nursing Science, International University of Korea, Jinju 660-759, Republic of Korea
dDepartment of Internal Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Republic of Korea
eDepartment of Anatomy, Seoul National University College of Medicine, Seoul, Republic of Korea
fDepartment of Microbiology, Gyeongsang National University School of Medicine, Jinju, Republic of Korea
a r t i c l e i n f o a b s t r a c tArticle history:
Received 21 June 2013
Received in revised form 22 August 2013
Accepted 1 September 2013
Available online 11 September 2013
Keywords:
Gulo/ mice
Gastric cancer
Helicobacter pylori
Diethylnitrosamine
Proteome analysis
14-3-3 IsoformsUnlike most other mammals, human bodies do not have the ability to synthesize vitamin C inside of their
own bodies. Therefore, humans must obtain vitamin C through daily diet. Gulo/ mice strain is known
with deﬁciency, in which vitamin C intake can be controlled by diet like human, and would be valuable
for investigating the molecular mechanism of various diseases. In the present study, we established
Gulo/ mice model and investigated the differentially expressed proteins in stomach tissue of Gulo/
mice after Helicobacter pylori-infected, and followed by DENA, using immunohistochemistry and proteo-
mic approach. The results of immunohistochemistry analysis of stomach tissue showed that the tumor
suppressor, p53 protein, expression was signiﬁcantly decreased (p < 0.05) but not messenger RNA
(mRNA) transcriptional level, and 14-3-3e, 14-3-3d, Ki-67 and cleaved caspase 3 expressions were signif-
icantly increased (p < 0.05) by H. Pylori infection, and followed by DENA treatment in Gulo/ mice. More-
over, knockdown of 14-3-3 isoforms (14-3-3e, 14-3-3r, 14-3-3f and 14-3-3g) were signiﬁcantly
increased sub-G1 phase (characteristics of apoptosis) in AGS cells and, phenotypic changes like cell
shrinkage, density and cleaved nuclei were also observed. Proteome analyses showed that 14-3-3r,
14-3-3g, and tropomyosin alpha-1 chain were down-regulated, and Hspd1 protein and HSC70 were
up-regulated after H. Pylori-infection, and followed by DENA. The combined results of immunohisto-
chemistry and proteomic analysis suggest that H. pylori altered the p53 and 14-3-3 isoforms expression
and DENA further enhanced the H. pylori effect, which might be involved in carcinogenesis and metastasis
of gastric cancer on Gulo/ mice.
 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Globally, gastric cancer (stomach cancer) is the second leading
cause of cancer-related death, next to lung cancer, and approxi-
mately 989,600 new cases are diagnosed and 738,000 deaths every
year [1]. Currently, the diagnosis is based on clinical, endoscopic,
and histological criteria of gastric cancer patients; moreover, it is
very difﬁcult while examining many patients. The alternativepossibility is to use laboratory animals, like mouse and rat for such
studies. Vitamin C (ascorbic acid) is an excellent antioxidant, and
an essential nutrient of most living tissues [2]. Humans must ob-
tain vitamin C through daily diet due to a lack of L-gulono-g-lac-
tone oxidase (GULO), gene encoding the key enzyme in ascorbic
acid biosynthesis of most mammalian species. Even though hu-
mans overcome ascorbic acid deﬁciency by diet, its requirements
vary greatly among the individuals for optimal health. The most
common laboratory animals, including the mouse and rat possess
a functional GULO gene that can readily synthesize ascorbic acid
when destitute of this vitamin in the diet. In such case, ascorbic
acid deﬁciency animal would be an appropriate and prominent
model for human disease studies. Recently, Gulo/ mice model
have been used for in vivo experiment [3] and these Gulo/ mice
strain is known with deﬁciency, in which vitamin C intake can be
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the molecular mechanism of various diseases.
Helicobacter pylori infection is a major cause of gastric cancer [4]
and it is known to be an important pathogen associated with var-
ious severe gastric diseases, including peptic ulcers, chronic gastri-
tis, and gastric cancer [5]. Epidemiological studies have reported
that H. pylori infection is a risk factor for gastric carcinoma and
vitamin C deﬁciency humans linked to more severe H. pylori-asso-
ciated gastritis and a gastric cancer risk is also higher [6,7]. How-
ever, the mechanism by which H. pylori promotes the gastric
epithelial cells to become cancerous is not fully understood. More-
over, Nitrosamines are the most important carcinogens that are in-
volved in development of esophageal squamous-cell cancer (SCC)
and gastric adenocarcinoma [8]. Diethylnitrosamine (DENA) is a
well-known N-nitrous compound that provokes esophageal cancer
in laboratory animals [9,10]. It has been ﬁrst reported that diet-
hylnitrosamine (DENA) used for the induction of esophageal and
gastric tumors in hamsters [11]. Presently, only limited studies
are available regarding DENA effects on gastric cancer. Hence, the
combined effects of H. pylori-infection and DENA treatment in lab-
oratory animals like Gulo/ mice will provide new leads to under-
stand the mechanism between gastric cancer, H. pylori and DENA.
With recent advances in proteomics, protein biomarker discov-
ery is now a major area of proteome research. Proﬁling methods
like matrix-assisted laser desorption/ionization time-of-ﬂight
(MALDI-TOF/MS) mass spectrometry analyses of animal tissues
and ﬂuids are promising techniques for biomarker discovery. In
present study, we established in vivo Gulo/ mice model like hu-
mans (it cannot synthesis vitamin C) and to identify the proteins
which are differentially expressed in H. pylori-infected alone and/
or combined with DENA that may play important roles in the path-
ological mechanism of H. pylori-induced gastric diseases and
enhancement effect of DENA. To our knowledge, this is the ﬁrst
study using proteomics approach to proﬁle protein changes in
Gulo/ mice model after H. pylori infection alone and/or combined
with DENA.2. Materials and methods
2.1. Chemical and reagents
Materials and chemicals used for electrophoresis were obtained
from BioRad (Hercules, CA, USA). Antibodies 14-3-3e and 14-3-3d
were obtained from Bioworld Technology Inc. (St. Louis Park,
MN, USA), and p53 was purchased from Millipore (Billerica, MA,
USA). RPMI 1640 medium was purchased from Hyclone (Logan,
UT, USA). Fetal bovine serum (FBS) and antibiotics (streptomycin/
penicillin) were purchased from Gibco (BRL Life Technologies,
Grand Island, NY, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-dephe-
nyltetrazolium bromide (MTT), dimethylsulfoxide (DMSO), and
RNase A were obtained from Sigma–Aldrich (St. Louis, MO, USA).
The 14-3-3e siRNA (h), 14-3-3r siRNA (h), 14-3-3f siRNA (h) and
14-3-3g siRNA (h) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Vitamin C (Ascorbic acid ) was provided by
Animal Resources Research Bank (ABRB). All other chemicals used
in this study were purchased from AMRESCO (Solon, OH, USA) and
Sigma–Aldrich (St. Louis, MO, USA). All the chemicals used were of
the highest grade available commercially.Fig. 1. A schematic representation of experimental procedure followed in Gulo/
mice.2.2. Experimental design and sample collection
We followed Animal Science guidelines for animal experimen-
tation. Gulo/ mice were kindly provided by Prof. Wang Jae Lee
(Department of Anatomy, Seoul National University College of
Medicine). Gulo/ breeding pairs were originally obtained fromthe Mutant Mouse Regional Resource Centers, University of Cali-
fornia at Davis. Genotypes of the off springs (Ed note: offspring)
were evaluated by PCR as recommended [12]. Female Gulo/
and C57BL/6 mice at 6–7 weeks of age were used, and they were
maintained in speciﬁc pathogen free condition in the animal facil-
ity at the Gyeongsang National University School of Medicine with
the animal experiments protocol reviewed and approved by Ethics
Committee of the Gyeongsang National University. Gulo/ mice
were supplemented with 1.0 g/L of vitamin C in drinking water
to prevent the death by vitamin C deﬁciency [13]. Gulo/ mouse
was divided into three groups; the control, H. Pylori infected group
and H. Pylori infected followed by DENA treatment. In all three
groups, vitamin C was supplemented (20 mg/animal/day, PO) and
only group 3 was treated with DENA (10 mg/L, PO). A schematic
representation of whole experimental procedure showed in
Fig. 1. After 48 weeks, sacriﬁced all animals, stomach tissues were
collected. Samples were stored at 70 C until analysis.
2.3. Immunohistochemistry
We performed immunohistochemistry to evaluate the expres-
sion of p53, 14-3-3e, 14-3-3d, Ki-67 and cleaved caspase 3 in
Gulo/ mice mouse stomach tissue of all three groups, as men-
tioned in the experimental design. Collected samples were im-
mersed in 4% prarformaldehyde for 48 h, and then processed for
parafﬁn wax histology. In addition, 5 and 10 lm thick parafﬁn
embedded lung slices were collected. To estimate histological
changes, Hematoxylin–eosin (H–E) staining was carried out.
Immunohistochemistry for p53, 14-3-3e, 14-3-3d, Ki-67 and
cleaved caspase 3 were performed using rabbit monoclonal anti-
bodies. Immunoreactivity was visualized with an avidin–biotin
peroxidase reaction (PK-4001, Vectastain ABC Kit). The peroxidase
reaction was developed using a 3, 30-diaminobenzidine tetrahydro-
chloride (D-5905, Sigma). The sections were counterstained with
hematoxylin before being mounted.
2.4. Real-time polymerase chain reaction (RT-PCR)
Total RNA was isolated from Gulo/ mice stomach tissues of
control, H. pylori infected group and H. pylori infected combined
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nology, Seoul, Republic of Korea) and reverse-transcribed into
cDNA by commercially available cDNA synthesis kits (iScript cDNA
Synthesis Kit; Bio-Rad) according to the manufacturer protocol.
The real-time PCR was performed on a CFX96 real-time PCR system
(Bio-Rad) with QuantiTect SYBR Green PCR Master Mix
(Qiagen, Valencia, CA, USA). The primers were designed with the
following sequences: p53, 50-ACATGACGGAGGTCGTGAGA-30
(forward), 50-TTTCCTTCCACCCGGATAAG-30 (reverse); and b-actin,
50-GGCTGTATTCCCCTCCATCG-30 (forward) and 50-CCAGTTGGTAAC
AATGCCATGT. All reactions were performed in triplicate and
the messenger RNA (mRNA) expression of p53 was normalized to
b-actin mRNA in the same sample.2.5. Protein extraction and two-dimensional gel electrophoresis (2-DE)
The Gulo/ mice stomach tissues were lysed in a lysis buffer
(7 M urea, 2 M thiourea, and 4% (w/v) CHAPS) on ice for 1 h. The ly-
sates were centrifuged at 14,000 rpm for 15 min at 4 C, and the
collected supernatants were stored at 80 C until analysis. Stom-
ach tissue proteins were precipitated in lysates with equal volume
(1:1) of 20% v/v trichloroacetic acid and dissolved in 7 M urea, 2 M
thiourea and 4% (w/v) CHAPS, 0.5% (v/v) IPG buffer, 1% dithiothre-
itol (DTT). Protein concentration was determined by the Non-Inter-
fering™ protein assay kit (G-Biosciences, St. Louis, MO, USA)
according to the manufacturer’s protocol. Immobilized 18 cm lin-
ear pH gradient (IPG) strips, pH 4–7, were rehydrated in rehydra-
tion buffer (7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.002%
Bromophenol blue). For the ﬁrst dimension, 100 lg protein was fo-
cused using the Ettan IPG Phor II (GE Healthcare) at 50 V for 1 h,
followed by 200 V for 1 h, 500 V for 30 min, 4000 V for 30 min,
4000 V for 1 h, 10,000 V for 1 h, 10,000 V for 13 h, and 50 V for
3 h. The focused strips were equilibrated twice for 15 min each
time, ﬁrst with 10 mg/ml DTT and then with 40 mg/ml iodoaceta-
mide (IAA) prepared in equilibration buffer containing 50 mM
Tris–HCl (pH 8.8), 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, and
0.002% (w/v) bromophenol blue. The focused proteins were then
separated in the second dimension by 12% linear gradient SDS–
PAGE with a constant current of 20 mA/gel at 20 C. Gels were
run until the Bromophenol dye front reached the end of the gel.2.6. 2-DE gel analysis, protein detection and in-gel digestion
The gels were stained with silver nitrate, similar to the method
described by Swain and Ross (1995) [14] with slight modiﬁcations.
Three independent gels were performed in triplicate. Gels were
scanned and Image analysis was performed using Progenesis
Samespots software (Nonlinear Dynamics, Newcastle, UK). Using
this software, the differentially expressed spots were identiﬁed
by automatically matching the detected protein spots. Those spots
differing signiﬁcantly (p < 0.05) in their intensities with a fold-
change P2 were used for further analysis. Selected protein spots
were excised manually from the two-dimensional electrophoresis
(2-DE) gel and protein digestion was performed [15] with slight
modiﬁcations. Brieﬂy, the excised gel pieces were washed with
100 ll of 100 mM NH4HCO3 for 5 min and then dehydrated in
100 ll of acetonitrile for 10 min. After dried in a lyophilizer
(SFDSM06, Samwon Freezing Engineering Co., Busan), the gel
pieces were rehydrated in 5–10 ll of 50 mM NH4HCO3, containing
20 ng/ll trypsin (Promega, Madison, WI, USA) on ice. After 45 min,
the trypsin solution was removed and replaced with 10–20 ll of
50 mM NH4HCO3 without trypsin, and digestion was carried out
for a minimum of 16 h at 37 C. These peptide mixtures were col-
lected and analyzed by mass spectrometry.2.7. MALDI-TOF/ TOF MS analysis and database searching
Peptide mixtures were targeted onto a MALDI-TOF/TOF plate
and analyzed by using a Voyager-DE STR mass spectrometer (Ap-
plied Biosystems, Franklin Lakes, NJ, USA), equipped with delay
ion extraction. Mass spectra were obtained over a mass range of
800–3000 Da. For identiﬁcation of proteins, the peptide mass ﬁn-
gerprinting data were used to search against the Swissprot data-
base, using the Mascot program (http://www.matrixscience.com).
The following parameters were used for database searches: taxon-
omy, Mus musculus (Mouse); cleavage speciﬁcity, trypsin with one
missed cleavage allowed; peptide tolerance of 100 ppm for the
fragment ions; allowed modiﬁcations, Cys Carbamidomethyl
(ﬁxed), oxidation of Met (variable). Protein scores >84 were consid-
ered statistically signiﬁcant (p < 0.05).
2.8. Cell culture
AGS human gastric cancer cells obtained from the Korea Cell
Line Bank (Seoul, Korea) were grown in RPMI-1640 medium sup-
plemented with 10% heat-inactivated fetal bovine serum and 1%
penicillin and streptomycin in a humidiﬁed atmosphere of 5%
CO2 at 37 C.
2.9. Cell viability assay and morphological examination
The AGS cells transfected with 14-3-3e siRNA (h), 14-3-3r siR-
NA (h), 14-3-3f siRNA (h) and 14-3-3g siRNA (h), the 3-(4,5-dim-
ethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-based
assay was performed on AGS cells after 24 h incubation. Cells were
seeded in a 12-well plate and incubated with siRNA for 24 h. After
incubation, 100 ll of a MTT solution (5 mg/ml in 1 phosphate
buffered saline, PBS) was added to the wells and incubated for
3 h. Then, 500 ll of dimethyl sulphoxide (DMSO) was added to
each well after medium was removed completely to dissolve the
cellular crystalline deposits. The optical density was measured of
at 540 nm using an ELISA plate reader. For phenotypic morpholog-
ical examination, cells were grown on 6-well plates, treated with
siRNA for 24 h for 24 h, and then examined under light microscopy
(400).
2.10. Cell cycle analysis
A total of 60  104 cells/well was plated in 6-well plates and
incubated overnight at 37 C in an atmosphere of 5% CO2. The cells
were transfected with 14-3-3e siRNA (h), 14-3-3r siRNA (h), 14-3-
3f siRNA (h) and 14-3-3g siRNA (h) and incubated for 24 h. Cells
were trypsinised, washed twice with cold PBS, and centrifuged.
The pellet was ﬁxed using cold 70% ethanol (v/v) for 30 min at
4 C. The cells were washed with PBS and stained with propidium
iodide (PI) solution (50 lg/ml) containing RNase A (0.1 mg/ml) in
PBS (pH 7.4) for 30 min in the dark. Flow cytometry analyses were
performed using a FACSCalibur apparatus (Becton Dickinson, San
Jose, CA, USA). The data were analyzed using CellQuest software
(Becton Dickinson).
2.11. Nuclear morphology
For nuclear morphological analysis, cells were seeded onto cov-
er glasses and transfected with 14-3-3e siRNA (h), 14-3-3r siRNA
(h), 14-3-3f siRNA (h) and 14-3-3g siRNA (h) for 24 h. Cells were
ﬁxed with 3.7% paraformaldehyde for 15 min, washed three times
(10 min each), permeabilized with 1% Triton X-100 and stained
with Hoechst 33342 ﬂuorescent dye (0.5 lg/ml) for 15 min. Nucle-
ar morphology was examined by ﬂuorescence microscopy (Leica)
using a 1000 objective.
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The data represent the mean ± standard deviation (SD) of the
three independent experiments. The statistical signiﬁcance be-
tween the control and test groups (H. pylori infected group and
H. pylori infected followed by DENA) were calculated by a Student’s
t-test. A p value < 0.05 was considered as signiﬁcant.3. Results and discussion
Ascorbic acid (vitamin C) is an essential dietary antioxidant
in humans. As a result of a lack of L-gulonolactone oxidase,
unlike most other mammals, humans are unable to synthesize
vitamin C; thus, humans must intake by their daily diet, is
critical for maintaining normal levels of vitamin C [16]. Epide-
miological studies have shown that dietary ascorbic acid ap-
pears to protect against gastric cancer [17,18]. However, role
of vitamin C in cancer treatment is still controversial. In the
present study, we established Gulo/ mice model like human,
that vitamin C should be orally supplemented daily. Gulo/Fig. 2. Immunohistochemistry of p53 (A), 14-3-3e (B), 14-3-3d (C) in Gulo/ mice s
paraformaldehyde. Microscopic observations were conducted by LEICA DM 6000 B m
experiments. The asterisk (*) indicates a signiﬁcant difference from the control group (⁄mice were divided into three groups, such as the control
group, H. pylori infected group and H. pylori infected, followed
by DENA treatment. In all three groups, vitamin C was supple-
mented (20 mg/animal/day, PO), since Gulo/ mice is unable
to synthesize vitamin C and it will die within 6 weeks due
to severe scurvy. Previous studies have reported that vitamin
C insufﬁciency affects severe defects on cardiac function and
skeletal systems due to the deﬁciency on the production of
hormones and collagen [19,20]. Recently, Kim et al. [13] have
ﬁrst demonstrated phenotypic changes of Gulo/ mice upon
vitamin C withdrawal (i.e.) Gulo/ mice supplemented with
0.33 g/L could not reach at the concentration in wild-type
and Gulo/ mice supplemented with 3.3 g/L of vitamin C. In
the present study, vitamin C supplemented Gulo/ mice may
not be physiologically identical with wild-type mice but res-
cued the Gulo/ mice from vitamin C deﬁciency and protected
from scurvy. Taken together, we investigated the expression of
p53, 14-3-3e, 14-3-3d, Ki-67 and cleaved caspase 3, and
differentially expressed protein in Gulo/ mice by using
immunohistochemistry and 2-DE combined with MALDI-TOF/
TOF MS analysis, respectively.tomach tissue. After 48 weeks, stomach tissue were collected and ﬁxed with 4%
icroscope (200). Data represent the mean ± SD of three replicates independent
p < 0.05).
Fig. 3. The mRNA expression of p53 in Gulo/ mice stomach tissue. The real-time
PCR was performed on a CFX96 real-time PCR system (Bio-Rad). Data represent the
mean ± SED of three replicates independent experiments and the mRNA expression
of p53 was normalized to b-actin mRNA in the same sample. The asterisk (*)
indicates a signiﬁcant difference from the control group (⁄p < 0.05).
Fig. 4. Immunohistochemistry of Ki-67 and (A), cleaved caspase 3 (B) in Gulo/ mice
paraformaldehyde. Microscopic observations were conducted by LEICA DM 6000 B m
experiments. The asterisk (*) indicates a signiﬁcant difference from the control group (⁄
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combined with DENA treated groups
H. Pylori, a gram negative bacterium that colonizes the mucosal
layer overlying the gastric epithelium of the human stomach [21].
We tested the expression of p53 protein (tumor suppressor gene),
known to be involved in G1 cell cycle arrest to allow DNA repair as
well as induction of apoptosis after DNA damage [22], which is re-
ported to be frequently mutated in a wide variety of human can-
cers [23–25]. The previous studies have reported that the
complete loss of p53 expression greatly enhanced stomach carci-
nogenesis [26]. In the present study, immunohistochemistry result
shows that p53 was signiﬁcantly decreased in H. pylori-infected
and combined with DENA (p < 0.05) treated Gulo/ mice stomach
tissue when compared with control (Fig. 2A). Especially, no expres-
sion was found in the H. pylori-infected combined with DENA trea-
ted group. However, no signiﬁcant changes were found in mRNA
expressions of all three groups (Fig. 3). This expression at tran-
scription and translational level in p53 was vary because of tran-
scriptional activity of a gene (mRNA) is not always representative
of cellular protein expression due to posttranslational modiﬁca-
tions of p53. This result revealed that p53 decreased expression
at translational level might be involved in stomach carcinogenesis
due to H. pylori-infection and DENA enhanced the gastric cancer
with H. pylori-infection in Gulo/ mice.3.2. The expression of 14-3-3e and 14-3-3d were increased in H.
pylori-infected and combined with DENA treated groups
The 14-3-3 proteins have seven isoforms in mammals [27]. We
examined the expression of 14-3-3e and 14-3-3d in Gulo/ micestomach tissue. After 48 weeks, stomach tissue were collected and ﬁxed with 4%
icroscope (200). Data represent the mean ± SD of three replicates independen
p < 0.05 and ⁄⁄p < 0.01).t
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14-3-3d were signiﬁcantly increased in H. pylori-infected and com-
bined with DENA (p < 0.05) treated Gulo/ mice stomach tissue
when compared with the control (Fig. 2B and C). Particularly, the
expression was found in mucosa layer of the stomach tissue. H. py-
lori is gram negative bacterium found in the human gastric mucosa
layer. Increased expression of 14-3-3e was found in the lung,
breast, stomach and oral squamous cell carcinomas [28–31]. The
expression of 14-3-3e and 14-3-3d in mucosa layer might be a
new clue to study the protein target of H. pylori-infection and
stomach cancer carcinogenesis. This increased expression of 14-
3-3e and 14-3-3d indicates that H. pylori directly involved in gastri-
tis and DENA enhanced the gastric cancer in Gulo/ mice.3.3. The expression of Ki-67 and cleaved caspase 3 were increased in H.
pylori-infected and, combined with DENA treated groups
Ki-67 is a nuclear proliferation-associated antigen expressed
the G1, S, G2, and M phases, but absent in quiescent and resting
cells [32]. We examined Ki-67 and cleaved caspase 3 by using
Immunohistochemistry to evaluate the proliferative activities andFig. 5. Two-dimension electrophoresis pattern of Gulo/mice stomach (A) Control, (B) H
on IPG-strips with pH 4–7 in the ﬁrst dimension and then on 12% polyacrylamide gel oapoptosis index in stomach tissue of Gulo/mice after H. pylori-in-
fected, and followed by DENA. The higher expression of Ki-67 in
intestinal type-compared with diffuse type adenocarcinomas has
been reported [33]. Moreover, the expression of Ki-67 was higher
in gastric carcinomas. And also, the caspase-3 was more strongly
expressed in intestinal type cancers than in the diffuse type [34].
In addition, there was marked difference in the expression of cas-
pase-3 in tumor tissue compared to normal mucosa [35]. In the
present study, the expressions of Ki-67 and cleaved caspase 3 were
signiﬁcantly increased in H. pylori-infected and combined with
DENA (p < 0.05 and p < 0.01) treated Gulo/ mice stomach tissue
when compared with control (Fig. 4A and B). These results revealed
that, H. pylori and DENA increased Ki-67 (cell proliferation index)
and cleaved caspase 3 (apoptosis index) that’s implicated in gastric
carcinogenesis of stomach tissue of Gulo/ mice.3.4. Differentially expressed proteins in Gulo/ mice stomach H.
pylori-infected and combined treatment with DENA
The differentially expressed proteins in H. pylori-infected and
combined with DENA treated Gulo/ mice stomach tissue were. pylori-infected, (C) H. pylori and DENA treated. Proteins were isolated and separated
n second dimension. The gels were silver stained.
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group. The 100 lg of total proteins from all three groups were sep-
arated by IEF on 18 cm IPG strips in the ﬁrst dimension and 12%
SDS–PAGE in the second dimension. We observed a total of
approximately 600 protein spots in silver stained gels. The 2-DE
maps of the three groups of Gulo/ mice stomach are shown in
Fig. 5. A total of 28 statistically signiﬁcant altered protein spots
were identiﬁed (P2-fold expression, p < 0.05). Successfully, 24
proteins were identiﬁed by using a MALDI-TOF/TOF/MS. Table 1
lists the differentially expressed protein identiﬁed and their
expression patterns. Of the 24 proteins, 17 were down-regulated,
including 14-3-3r, 14-3-3g, tropomyosin alpha-1 chain, and 7
were up-regulated, including Hspd1 protein and HSC70.
In our proteome results showed that 14-3-3r and 14-3-3g
were decreased in the H. Pylori-infected group, and the H. Pylori in-
fected followed by DENA treated group when compare to the con-
trol group. The 14-3-3 proteins constitute a family of conserved
proteins found in all eukaryotic organisms that are key regulators
of a large number of processes including apoptosis, mitogenic sig-
naling and cell-cycle checkpoints [36]. The 14-3-3 proteins are new
targets of cancer research; there are in total 7 isoforms of 14-3-3
proteins that have been reported in mammals and each one has
a different expression [37]. In the current study, we knock down
14-3-3 isoforms (14-3-3e, 14-3-3r, 14-3-3f and 14-3-3g) in hu-
man gastric cancer cell line AGS, to elucidate the possible roles of
14-3-3 isoforms. Firstly, AGS cells were transfected with 14-3-3
isoform siRNA and measured cell viability by MTT assay after
24 h incubation. The cell viability was decreased in 14-3-3e, 14-
3-3r, 14-3-3f and 14-3-3g transfected AGS cells to 93%, 77%,
86% and 79% respectively, after 24 h incubation (Fig. 6A). These re-
sults indicated that 14-3-3 isoforms might be having possible roleTable 1
List of differentially expressed proteins identiﬁed in Gulo/ mice stomach tissue by MALD
Spot
no.
Protein namea Accession
numbera
Theoretical Mr.
(kDa)b
Theoretica
valueb
1 Keratin, type I cytoskeletal
13
P08730 48066 4.79
2 14-3-3 protein eta P68510 28352 4.81
3 Keratin 13 B1AQ76 48066 4.79
4 Leukocyte elastase inhibitor
A
Q9D154 42719 5.85
5 Keratin 13 B1AQ76 48066 4.79
6 Chitinase-3-like protein 4 Q91Z98 45289 5.80
7 Tropomyosin alpha-1 chain P04692 23589 4.61
8 14-3-3 protein sigma O70456 27810 4.75
9 Alpha-S1-casein P19228 24477 4.85
10 60 kDa heat shock protein,
mitochondrial
P63038 59559 8.09
11 Smooth muscle gamma-actin Q61852 43251 5.36
12 Selenium-binding protein 1 P17563 53051 5.87
13 Actin, muscle 1A P53460 42303 5.23
14 Heat shock cognate 71 kDa
protein
P63017 71068 5.37
15 Keratin 13 B1AQ76 48066 4.79
16 Alpha-fetoprotein P02772 48792 5.47
17 Adenosine deaminase P03958 39935 5.49
18 Keratin 19 P19001 44515 5.28
19 Keratin, type I cytoskeletal
10
P02535 52824 4.91
20 Calmodulin P62158 19700 4.24
21 Chia protein Q91XA9 40456 4.67
22 Chia protein Q91XA9 40456 4.67
23 Tubulin alpha-8 chain Q9JJZ2 48221 4.97
24 Beta-actin A1E0X3 40937 5.66
a Entry name, protein name and accession number from SWISS-PROT database identi
b Theoretical molecular weight (kDa) and pI from SWISS-PROT database.
c Score is–10⁄log (p), where p is the probability that the observed match is a random
d Image analysis was performed using Progenesis Samespots software (Nonlinear Dyn
test) in their intensities with a fold-change P2.AGS cells proliferation. Microscopic observation showed that the
AGS cells undergone many morphological change such as cell
shrinkage and density, especially 14-3-3e and 14-3-3g knockdown
AGS cells compared with the control cells (Fig. 6B). When 14-3-3 is
down-regulated, cells fail to maintain a G2/M arrest and induced
apoptosis as a result of DNA damage [38]. Hence, ﬂow cytometry
was performed to investigate the distribution of AGS cell cycle
phases after knock down 14-3-3 isoforms. There was statistically
signiﬁcant accumulation of cells with sub-G1 DNA content (Char-
acteristics of apoptosis) 14-3-3e (23.17%), 14-3-3r (27.433%), 14-
3-3f (27.76%) and 14-3-3g (27.66%), meanwhile G2/M phase cells
were signiﬁcantly decreased (Fig. 6C). To determine whether knock
down 14-3-3 isoforms affect the cell viability due to apoptosis,
morphological change was observed using Hoechst staining, with
particular attention given to the apoptosis hallmarks of condensed
chromatin near the nuclear membrane and DNA fragmentation.
Condensed and cleaved nuclei were observed in AGS cells after
knockdown of 14-3-3e, 14-3-3r, 14-3-3f and 14-3-3g, whereas
the non-treated cells displayed a normal size and round shape nu-
cleus (Fig. 6D). These results suggest that the knockdown of 14-3-3
isoforms could induce apoptosis in AGS cells. The one of the iso-
form 14-3-3r was shown to be regulated by p53 and to play a role
in the G2-M-phase checkpoint [39] and it’s negatively regulates
cell cycle progression through cyclin-dependent kinases associa-
tion [40,41]. Moreover, the 14-3-3r is also tumor suppressor gene
as positive regulators of p53 protein, and its decreased expression
reported in many cancer types [42]. In addition, overexpression of
14-3-3r can suppress tumor growth [43,42]. Further, another iso-
form 14-3-3h has been down-regulated in most of the adenocarci-
nomas [44]. These results revealed that the decreased expression
of 14-3-3r and 14-3-3g might be involved in H. pylori mediatedI-TOF/ TOF MS.
l pI Sequence
coverage (%)
Mouse
scorec
Control vs H. pylori-
infectedd
Control vs H. pylori
+ DENAd
43 360 ; ;
18 101 ; ;
43 376 ; ;
21 91 ; ;
38 320 ; ;
28 180 ; ;
37 169 ; ;
48 179 ; ;
28 93 " "
17 118 " "
34 302 ; ;
40 359 ; ;
17 86 ; ;
25 167 " "
42 412 ; ;
26 164 ; ;
40 382 ; ;
39 248 " "
37 357 ; ;
26 182 " "
13 138 " "
35 290 " "
29 258 ; ;
29 162 ; ;
ﬁed by MALDI-TOF/TOF/MS.
event, Protein scores greater than 84 are signiﬁcant (p < 0.05).
amics, Newcastle, UK). Those spots differing signiﬁcantly (p < 0.05, one-way ANOVA
Fig. 6. Phenotypic changes in 14-3-3 isoforms (14-3-3e, 14-3-3r, 14-3-3f and 14-3-3g) knockdown AGS cells. (A) The cell viability determined by MTT assay. (B)
Morphology of AGS cells were examined by light microscopy (400). (C) Cell cycle distribution and apoptotic cells were assessed by PI staining. (D) Morphological change
was observed using Hoechst staining (White arrow indicates cleaved nuclei). The asterisk (*) indicates a signiﬁcant difference from the control group (⁄p < 0.05 and ⁄⁄p < 0.01).
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addition, heat shock proteins (HSP) proteins are mainly involved
in a wide variety of physiological and pathological conditions
[45]. Over production of HSP protects malignancy transformed
cells from apoptotic cell death and foasters resistance to chemo-
therapeutic agents [46]. In this study, Hspd1 protein and HSC70
protein were increased in the H. Pylori infected group and the H.
Pylori infected followed by DENA treated group when compared
to the control group. The combined results of immunohistochem-istry and proteome results revealed that H. pylori altered the p53
and 14-3-3 isoforms expression and DENA enhanced the H. pylori
effect in Gulo/ mice.
In summary, immunohistochemistry analysis showed that the
expression of p53 protein was signiﬁcantly decreased at transla-
tional level but not mRNA level, and 14-3-3e, 14-3-3d, Ki-67 and
cleaved caspase 3 expressions were signiﬁcantly increased after
H. Pylori-infection and followed by DENA in stomach tissue of
Gulo/ mice. In addition, proteome results showed that 14-3-3r,
A. Nagappan et al. / Chemico-Biological Interactions 206 (2013) 143–152 15114-3-3g, and tropomyosin alpha-1 chain were down-regulated,
and Hspd1 protein and HSC70 were up-regulated after H. Pylori
infection, and followed by DENA.in Gulo/ mice. Moreover, knock-
down of 14-3-3 isoforms (14-3-3e, 14-3-3r, 14-3-3f and 14-3-3g)
were signiﬁcantly increased sub-G1 phase (characteristics of apop-
tosis) in AGS cells and, phenotypic changes like cell shrinkage, den-
sity and cleaved nuclei were also observed. These results suggest
that H. pylori altered the p53 and 14-3-3 isoforms expression and
DENA enhanced the H. pylori effect in stomach tissue of Gulo/
mice, which might be involved in carcinogenesis and metastasis
of gastric cancer. Some may have potential as biomarkers in the
early diagnosis and therapy of gastric cancer. Moreover, these
identiﬁed proteins needed to be veriﬁed by immune-blotting to
make this data more valuable. In further study, we will demon-
strate the protective effect of vitamin C at high dosage against gas-
tric cancer after H. pylori and DENA treatment using vitamin C
deﬁciency Gulo/ mice model.
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